Exact Sciences Corp (EXAS)

Industry Diagnostics & Research

This stock can be held in an Investment ISA and an Investment Account
Sell

$53.03

Buy

$53.50

arrow-up$1.77 (+3.43%)

Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
Prices updated at 13 May 2025, 00:38 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Kevin T. Conroy
CEO
Mr. Kevin T. Conroy
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
7,000
Head office
5505 Endeavor Lane
Madison
United States
53719
mobile
+1 608 284-5700
letter
meganjones@exactsciences.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Ms. Leslie L. Trigg
Director
-----
Ms. Kimberly J. Popovits
Director
-----
Ms. Katherine S. Zanotti
Independent Director
0.09m--0.34m-
Mr. Kevin T. Conroy
Chairman of the Board, President and Chief Executive Officer
1.08m--15.54m-
Mr. Paul J. Clancy, M.B.A.
Independent Director
0.10m--0.36m-
Mr. Daniel Joseph Levangie
Independent Director
0.09m--0.35m-
Mr. Jacob Orville
Executive Vice President and General Manager, Screening
0.62m--4.43m-
Mr. James E. Doyle
Lead Independent Director
0.13m--0.38m-
Mr. D. Scott Coward
Director
0.08m--0.33m-
Ms. Shacey Petrovic
Independent Director
0.09m--0.34m-
Ms. Sarah Condella
Executive Vice President, Human Resources
0.51m--2.65m-
Mr. Michael J. Barber
Independent Director
0.10m--0.67m-
Mr. Brian Baranick
Executive Vice President and General Manager, Precision Oncology
0.60m--4.40m-
Mr. James Herriott
Senior Vice President, General Counsel and Secretary
-----
Mr. Aaron Bloomer
Executive Vice President, Chief Financial Officer and Principal Accounting Officer
0.43m0.60m-7.19m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
FMR LLC22,042,464-22042464-30 Apr 202511.91
FMR Inc20,753,5050.06959-894962-4.13406630 Apr 202511.00
Fidelity Management and Research Company20,753,5050.06959-894962-4.13406630 Apr 202511.00
Capital Research and Management Company17,833,0403.24736153490-30 Apr 20259.45
Capital World Investors17,537,6170.1496169632110.70822130 Apr 20259.30

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
14 May 2024-Mr. Kevin T. Conroy--779,944--
13 Nov 2024-Mr. Kevin T. Conroy51.351,001,3251,074,191--
08 Oct 2024-Mr. Brian Baranick70.0065,03012,758--
18 Sep 2024-Mr. Brian Baranick70.0065,03013,687--
05 Aug 2024-Jacob Orville--21,401--
05 Aug 2024-Mr. Brian Baranick55.7776,68414,616--
05 Aug 2024-Mr. Brian Baranick--21,401--
05 Aug 2024-Mr. Brian Baranick-----
05 Aug 2024-Mr. Brian Baranick--15,991--
13 Jun 2024-Ms. Katherine S. Zanotti--70,568--
13 Jun 2024-Mr. Paul J. Clancy, M.B.A.--20,640--
13 Jun 2024-Mr. Daniel Joseph Levangie--28,914--
13 Jun 2024-Mr. James E. Doyle--56,049--
13 Jun 2024-Mr. D. Scott Coward--50,583--
13 Jun 2024-Ms. Shacey Petrovic--16,406--
13 Jun 2024-Ms. Kathleen Sebelius--32,671--
13 Jun 2024-Mr. Michael J. Barber--5,939--
30 Apr 2024-Jacob Orville--14,542--
01 May 2024-Jacob Orville60.156,13514,440--
01 May 2024-Mr. Kevin T. Conroy60.1569,4731,156,191--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.